Annual CFO
-$107.56 M
-$6.53 M-6.46%
December 31, 2021
Summary
- As of February 8, 2025, ALBO annual cash flow from operations is -$107.56 million, with the most recent change of -$6.53 million (-6.46%) on December 31, 2021.
- During the last 3 years, ALBO annual CFO has fallen by -$80.76 million (-301.31%).
Performance
ALBO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$29.63 M
+$6.76 M+18.58%
September 30, 2022
Summary
- As of February 8, 2025, ALBO quarterly cash flow from operations is -$29.63 million, with the most recent change of +$6.76 million (+18.58%) on September 30, 2022.
- Over the past year, ALBO quarterly CFO has dropped by -$2.15 million (-7.81%).
Performance
ALBO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$115.32 M
-$2.15 M-1.90%
September 30, 2022
Summary
- As of February 8, 2025, ALBO TTM cash flow from operations is -$115.32 million, with the most recent change of -$2.15 million (-1.90%) on September 30, 2022.
- Over the past year, ALBO TTM CFO has increased by +$6.54 million (+5.37%).
Performance
ALBO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ALBO Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.5% | -7.8% | +5.4% |
| 3 y3 years | -301.3% | -111.5% | -117.9% |
| 5 y5 years | -290.2% | -470.6% | -117.9% |
ALBO Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +113.3% | +22.8% | +7.2% | at low |
| 5 y | 5-year | +103.3% | at low | +139.0% | +22.8% | +117.9% | +5.7% |
| alltime | all time | +4396.6% | at low | -2798.5% | +22.8% | +4130.4% | +5.7% |
Albireo Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$29.63 M(-18.6%) | -$115.32 M(+1.9%) |
| Jun 2022 | - | -$36.39 M(+2.8%) | -$113.17 M(+4.5%) |
| Mar 2022 | - | -$35.41 M(+154.9%) | -$108.25 M(+0.6%) |
| Dec 2021 | -$107.56 M(+6.5%) | -$13.89 M(-49.5%) | -$107.56 M(-11.7%) |
| Sep 2021 | - | -$27.48 M(-12.7%) | -$121.86 M(+1.3%) |
| Jun 2021 | - | -$31.47 M(-9.4%) | -$120.35 M(+7.5%) |
| Mar 2021 | - | -$34.72 M(+23.1%) | -$111.95 M(+10.8%) |
| Dec 2020 | -$101.03 M(+90.9%) | -$28.20 M(+8.6%) | -$101.03 M(+18.5%) |
| Sep 2020 | - | -$25.97 M(+12.6%) | -$85.23 M(+16.3%) |
| Jun 2020 | - | -$23.07 M(-3.1%) | -$73.27 M(+15.9%) |
| Mar 2020 | - | -$23.80 M(+91.9%) | -$63.19 M(+19.4%) |
| Dec 2019 | -$52.92 M(+97.4%) | -$12.40 M(-11.5%) | -$52.92 M(+4.8%) |
| Sep 2019 | - | -$14.01 M(+7.8%) | -$50.52 M(+7.9%) |
| Jun 2019 | - | -$12.99 M(-3.9%) | -$46.80 M(+13.0%) |
| Mar 2019 | - | -$13.52 M(+35.3%) | -$41.42 M(+54.6%) |
| Dec 2018 | -$26.80 M(-2.8%) | -$10.00 M(-2.8%) | -$26.80 M(+8.3%) |
| Sep 2018 | - | -$10.29 M(+35.1%) | -$24.75 M(+25.9%) |
| Jun 2018 | - | -$7.62 M(-793.7%) | -$19.66 M(+9.6%) |
| Mar 2018 | - | $1.10 M(-113.8%) | -$17.94 M(-34.9%) |
| Dec 2017 | -$27.57 M(+213.8%) | -$7.95 M(+53.0%) | -$27.57 M(+40.5%) |
| Sep 2017 | - | -$5.19 M(-12.0%) | -$19.62 M(+17.0%) |
| Jun 2017 | - | -$5.90 M(-30.8%) | -$16.77 M(+24.9%) |
| Mar 2017 | - | -$8.53 M(+264.5%) | -$13.42 M(+7.0%) |
| Dec 2016 | -$8.78 M(-30.0%) | - | - |
| Sep 2016 | - | -$2.34 M(-8.3%) | -$12.54 M(-8.9%) |
| Sep 2016 | -$12.54 M(-31.1%) | - | - |
| Jun 2016 | - | -$2.55 M(-32.1%) | -$13.77 M(-18.4%) |
| Mar 2016 | - | -$3.76 M(-3.4%) | -$16.87 M(+1.3%) |
| Dec 2015 | - | -$3.89 M(+9.2%) | -$16.65 M(-8.5%) |
| Sep 2015 | -$18.20 M(-2.8%) | -$3.56 M(-36.9%) | -$18.20 M(+0.7%) |
| Jun 2015 | - | -$5.65 M(+59.2%) | -$18.08 M(+9.0%) |
| Mar 2015 | - | -$3.55 M(-34.8%) | -$16.59 M(-15.4%) |
| Dec 2014 | - | -$5.44 M(+57.9%) | -$19.62 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2014 | -$18.72 M(+0.9%) | -$3.45 M(-17.1%) | -$18.72 M(-0.7%) |
| Jun 2014 | - | -$4.16 M(-36.8%) | -$18.86 M(+1.4%) |
| Mar 2014 | - | -$6.58 M(+44.7%) | -$18.61 M(+1.1%) |
| Dec 2013 | - | -$4.54 M(+26.8%) | -$18.41 M(-0.8%) |
| Sep 2013 | -$18.55 M(+11.1%) | -$3.58 M(-8.1%) | -$18.55 M(-9.1%) |
| Jun 2013 | - | -$3.90 M(-38.8%) | -$20.41 M(+0.1%) |
| Mar 2013 | - | -$6.38 M(+35.9%) | -$20.39 M(+15.1%) |
| Dec 2012 | - | -$4.69 M(-13.8%) | -$17.72 M(+6.1%) |
| Sep 2012 | -$16.70 M(-8.5%) | -$5.44 M(+40.0%) | -$16.70 M(+14.5%) |
| Jun 2012 | - | -$3.89 M(+4.9%) | -$14.58 M(+2.8%) |
| Mar 2012 | - | -$3.70 M(+0.9%) | -$14.18 M(-7.3%) |
| Dec 2011 | - | -$3.67 M(+10.4%) | -$15.29 M(-16.2%) |
| Sep 2011 | -$18.25 M(-46.9%) | -$3.32 M(-4.6%) | -$18.25 M(-0.4%) |
| Jun 2011 | - | -$3.48 M(-27.8%) | -$18.33 M(-22.9%) |
| Mar 2011 | - | -$4.82 M(-27.2%) | -$23.78 M(-7.8%) |
| Dec 2010 | - | -$6.63 M(+94.8%) | -$25.80 M(-25.0%) |
| Sep 2010 | -$34.38 M(-2.5%) | -$3.40 M(-61.9%) | -$34.38 M(-15.0%) |
| Jun 2010 | - | -$8.94 M(+30.7%) | -$40.45 M(+3.6%) |
| Mar 2010 | - | -$6.84 M(-55.0%) | -$39.04 M(-5.1%) |
| Dec 2009 | - | -$15.20 M(+60.5%) | -$41.15 M(+16.7%) |
| Sep 2009 | -$35.26 M(+1.0%) | -$9.47 M(+25.8%) | -$35.26 M(-4.2%) |
| Jun 2009 | - | -$7.53 M(-15.8%) | -$36.79 M(-5.4%) |
| Mar 2009 | - | -$8.94 M(-4.0%) | -$38.90 M(+2.9%) |
| Dec 2008 | - | -$9.32 M(-15.3%) | -$37.80 M(+8.3%) |
| Sep 2008 | -$34.90 M(+125.0%) | -$11.00 M(+14.1%) | -$34.90 M(+17.8%) |
| Jun 2008 | - | -$9.64 M(+22.8%) | -$29.62 M(+23.2%) |
| Mar 2008 | - | -$7.85 M(+22.2%) | -$24.04 M(+25.2%) |
| Dec 2007 | - | -$6.42 M(+12.3%) | -$19.20 M(+23.8%) |
| Sep 2007 | -$15.51 M(+295.2%) | -$5.72 M(+41.0%) | -$15.51 M(+58.4%) |
| Jun 2007 | - | -$4.05 M(+34.6%) | -$9.79 M(+70.7%) |
| Mar 2007 | - | -$3.01 M(+10.5%) | -$5.74 M(+110.5%) |
| Dec 2006 | - | -$2.73 M | -$2.73 M |
| Sep 2006 | -$3.92 M(+64.0%) | - | - |
| Sep 2005 | -$2.39 M | - | - |
FAQ
- What is Albireo Pharma annual cash flow from operations?
- What is the all time high annual CFO for Albireo Pharma?
- What is Albireo Pharma annual CFO year-on-year change?
- What is Albireo Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Albireo Pharma?
- What is Albireo Pharma quarterly CFO year-on-year change?
- What is Albireo Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Albireo Pharma?
- What is Albireo Pharma TTM CFO year-on-year change?
What is Albireo Pharma annual cash flow from operations?
The current annual CFO of ALBO is -$107.56 M
What is the all time high annual CFO for Albireo Pharma?
Albireo Pharma all-time high annual cash flow from operations is -$2.39 M
What is Albireo Pharma annual CFO year-on-year change?
Over the past year, ALBO annual cash flow from operations has changed by -$6.53 M (-6.46%)
What is Albireo Pharma quarterly cash flow from operations?
The current quarterly CFO of ALBO is -$29.63 M
What is the all time high quarterly CFO for Albireo Pharma?
Albireo Pharma all-time high quarterly cash flow from operations is $1.10 M
What is Albireo Pharma quarterly CFO year-on-year change?
Over the past year, ALBO quarterly cash flow from operations has changed by -$2.15 M (-7.81%)
What is Albireo Pharma TTM cash flow from operations?
The current TTM CFO of ALBO is -$115.32 M
What is the all time high TTM CFO for Albireo Pharma?
Albireo Pharma all-time high TTM cash flow from operations is -$2.73 M
What is Albireo Pharma TTM CFO year-on-year change?
Over the past year, ALBO TTM cash flow from operations has changed by +$6.54 M (+5.37%)